About Alester Pharma Private Limited
Data last updated:
Alester Pharma Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 November 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2015PTC035840. Its GSTIN is 04AANCA9567G1ZB (Chandigarh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Rajeev Matta and Sonia Taluja.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 219 First Floor Motor Market Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.7 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹12.56 Lakh (net margin 2.2%) and EBITDA of ₹30.38 Lakh (EBITDA margin 5.3%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 15% over five years.
The company is associated with 1 brand: Alester Pharma. As per MCA filings, the company has open charges of ₹75 Lakh on record. Court records list 4 cases involving the company, including 2 filed by the company and 1 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alesterpharma.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressSCO 219 First Floor Motor Market Manimajra, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Alester Pharma Private Limited
The main business activity of Alester Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Alester Pharma Private Limited FY 2025 filings available
Alester Pharma Private Limited reported revenue of ₹5.7 Cr (up 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Alester Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 5% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Alester Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹30.38 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹12.56 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Alester Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Alester Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Alester Pharma Private Limited
Alester Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ethidrugs Research Lab Private Limited | ₹5.74 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Puducherry, India |
| Alytus Remedies Private Limited | ₹5.73 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | New Delhi, Delhi, India |
| Nymak Pharma Private Limited | ₹5.73 Cr (FY 2025) | •••• | •••• | •••• | Mundra, Gujarat, India | |
| Myrtace Healthcare Private Limited | ₹5.73 Cr (FY 2025) | •••• | •••• | -27.0% | •••• | Chennai, Tamil Nadu, India |
| Actiza Pharmaceutical Private Limited | ₹5.71 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Surat, Gujarat, India |
| Alester Pharma Private Limited this company | ₹5.7 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Chandigarh, India |
| Wenlay Medicare Private Limited | ₹5.7 Cr (FY 2024) | •••• | •••• | -74.0% | •••• | Mumbai, Maharashtra, India |
| Sowilo India Pharmaceuticals Private Limited | ₹5.69 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Delhi, India |
| Suyog Pharmaceuticals Private Limited | ₹5.69 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Thane, Maharashtra, India |
| Genova Biotechniques Private Limited | ₹5.69 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Hyderabad, Telangana, India |
| Evitalife Pharma Private Limited | ₹5.68 Cr (FY 2024) | •••• | •••• | -3.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Alester Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Alester Pharma Private Limited
Alester Pharma Private Limited is audited by VIKAS SANJIV & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VIKAS SANJIV & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Alester Pharma Private Limited
Alester Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Matta | Director | 27 Nov 2015 | 10 Years 10 Months | Current |
| Sonia Taluja | Director | 27 Nov 2015 | 10 Years 10 Months | Current |
| Adesh Saini | Director | 27 Nov 2015 | 10 Years 10 Months | Current |
| Kamna Matta Also directs: Uniphar Biotech Private Limited, Abiz Pharma Private Limited | Director | 27 Nov 2015 | 10 Years 10 Months | Current |
Ownership and Shareholding of Alester Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Alester Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Mar 2024 | Canara Bank | ₹75 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Alester Pharma Private Limited
Alester Pharma Private Limited has 4 court cases on record: 2 filed by Alester Pharma, 1 filed against it, 1 where it is another party. 2 cases are pending and 2 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 1 | 2 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Criminal case | Filed against the company by Algen Healthcare Limited | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Anjum Pharmaceutical | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Nizamabad, Telangana | Court case (IP) | Company is another party | Disposed |
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Alester Pharma Private Limited
Alester Pharma operates one associated brand: Alester Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Wholesaler and distributor of pharmaceutical tablets, syrups, and capsules. | alesterpharma.in |
Employees and EPFO Compliance at Alester Pharma Private Limited
Employment history and EPFO contributions of people linked to Alester Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Alester Pharma Private Limited
Alester Pharma Private Limited has 4 board changes on record since 2015: 4 appointments. The latest: Adesh Saini was appointed as Director on 27 Nov 2015.
Credit Ratings, Litigation & Regulatory Alerts for Alester Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Alester Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Alester Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Alester Pharma Private Limited
Alester Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AANCA9567G1ZB | Chandigarh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Alester Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alester Pharma Private Limited
Alester Pharma is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 November 2015 (11+ years old) and is registered under CIN U24232CH2015PTC035840.
Alester Pharma reported revenue of ₹5.7 Cr for FY 2025 (up 5% YoY).
Alester Pharma has 4 current directors:
- Rajeev Matta - Director
- Sonia Taluja - Director
- Adesh Saini - Director
- Kamna Matta - Director
Alester Pharma reported a net profit of ₹12.56 Lakh (net margin 2.2%) and EBITDA of ₹30.38 Lakh (EBITDA margin 5.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Alester Pharma is 10% over three years and 15% over five years. In the latest year (FY 2025) revenue rose 5%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Alester Pharma is 04AANCA9567G1ZB, registered in Chandigarh.
The CIN (Corporate Identification Number) of Alester Pharma is U24232CH2015PTC035840. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alester Pharma has 4 court cases on record: 2 filed by the company and 1 filed against it. 2 are pending.
Alester Pharma was incorporated on 27 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Alester Pharma by revenue are Ethidrugs Research Lab Private Limited, Alytus Remedies Private Limited, Nymak Pharma Private Limited, Myrtace Healthcare Private Limited, Actiza Pharmaceutical Private Limited and 5 more, all in the Pharma industry (Formulations).
Adesh Saini was appointed as Director on 27 Nov 2015. Kamna Matta was appointed as Director on 27 Nov 2015. Rajeev Matta was appointed as Director on 27 Nov 2015. Alester Pharma has 4 board changes on record in total.